New guidelines for diabetes treatment, mpox research, and healthcare system improvements discussed in comprehensive health ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

These are the 300 companies whose success goes beyond profits to include employee and customer sentiment, cybersecurity, ...

Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...

Vivani Medical, Inc. ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-acting drug implants, today reported financial results for the third quarter ended September ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Robert F. Kennedy Jr., one of President-elect Donald Trump’s advisers on health, is taking aim at the agency’s oversight on ...

Organogenesis (NASDAQ: ORGO) Q3 2024 Earnings Call Nov 12, 2024, 5:00 p.m. ET ...

The procedures are known as elective treatment because they are planned ... This is how the wait list has changed over time: ...

and Takeda but with no role in the current analysis. Some study authors declared affiliations with biotech, pharmaceutical, and/or device companies. Please see the original reference for a full list ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...